Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cambi ASA ( (DE:3W7) ) has issued an announcement.
Cambi ASA reported a decrease in revenue and EBITDA for the third quarter of 2025 compared to the previous year, but saw a significant increase in order intake due to a major biosolids handling contract and projects from its acquisition of CNP CYCLES. The company is expanding its offerings with new thermal hydrolysis models and anticipates lower operating profits in 2026 despite maintaining long-term growth expectations. The board approved an additional dividend, aligning with the company’s financial strategy.
More about Cambi ASA
Cambi is a global leader in biogas technology and solutions, specializing in wastewater treatment plants and anaerobic digestion facilities. Established in 1992, the company is known for its innovative and patented technologies that enhance renewable energy output, reduce operational costs, and minimize greenhouse gas emissions. Cambi’s thermal hydrolysis process is adaptable to regulatory changes and is suitable for various biosolids outlets. The company is listed on Euronext Growth Oslo.
Average Trading Volume: 46,418
Current Market Cap: NOK2.91B
Find detailed analytics on 3W7 stock on TipRanks’ Stock Analysis page.